- Sector: Pharmaceutical
- Country: Poland
Medicine on a mission
Established by Dr Marian Adamkiewicz PhD, in 1986, pharmaceutical and biotechnological company Adamed is centred on scientific thought and the development of its own patents.
“We manufacture nearly 580 new-generation products that are distributed in 65 countries across the globe,” explains Dr Małgorzata Adamkiewicz PhD, CEO of Adamed. “We establish scientific and industrial groups together with leading universities and scientific institutes, both in Poland and abroad.”
As a result, Adamed’s intellectual property is protected by more than 180 patents, in markets around the world, while the company has offices in Russia, Spain, Kazakhstan, the Czech Republic, Vietnam, Uzbekistan, Slovakia and Ukraine. It employs more than 2,000 people.
Driving this success is the firm’s powerful commitment to innovation, research and development, as Małgorzata explains: “The company was created and developed by Polish medical doctors with a focus on innovation in R&D activities.
“In 2016, we opened a new 3,000m2 state-of-the-art research and development centre, fully equipped with the latest research infrastructure. The department is currently working on advanced medical products used, among other things, in the treatment of oncological and central nervous system diseases. These are entirely innovative solutions.”
In 2017, Adamed signed a $50m investment agreement with Davi Pharm, one of the fastest-growing Vietnamese pharmaceutical companies. Signed in Hanoi in the presence of Polish President Andrzej Duda, and Vietnamese President Trân Đai Quang the deal provided a firm footing for further dynamic development in the Asia-Pacific region.
“It is part of Adamed’s internationalisation strategy, and we have further acquisitions planned in the near future,” adds Małgorzata.